Crossmark

Psychiatric adverse events linked to glucagon-like peptide 1 analogues: a disproportionality analysis in American, Canadian and Australian adverse event databases

Crossref DOI link: https://doi.org/10.1007/s11096-025-01943-x

Published Online: 2025-06-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Katranski, Jonah

Liang, Sihua

Morris, Deirdre

Suppiah, Vijayaprakash https://orcid.org/0000-0001-5496-935X
Lim, Chiao Xin https://orcid.org/0000-0001-5543-8411
Funding

Funding for this research was provided by:

Royal Melbourne Institute of Technology
License Information

Text and Data Mining valid from 2025-06-16

Version of Record valid from 2025-06-16
More Information

Article History

Received: 16 January 2025

Accepted: 14 May 2025

First Online: 16 June 2025

Conflicts of interest

: The authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below